April 16, 2025 – BOGOTA: The Colombian government declared a national health emergency on Wednesday in response to a surge in yellow fever cases across the country. This decision is aimed at controlling the outbreak and protecting public health.
Since the start of the year, the yellow fever outbreak has resulted in 74 confirmed cases and 34 deaths, as per Health Minister Guillermo Alfonso Jaramillo. Tolima remains the epicenter of the outbreak, with 22 newly detected cases.
Cases of yellow fever, an acute viral haemorrhagic disease transmitted by infected mosquitoes, are increasing at an alarming rate in Colombia. This has prompted the government to declare a nationwide emergency.
Healthcare officials in the country are persuading citizens to take preventive measures such as vaccination as the situation continues to escalate. This is expected to boost sales of yellow fever treatments.
According to Coherent Market Insights (CMI), the global yellow fever treatment market is projected to record a CAGR of 3.7% during the forecast period. Total industry size will likely reach USD 607.6 million by 2028. Rising cases of yellow fever, especially in countries like Colombia, will shape this growth.
“The new outbreak of yellow fever in Colombia is expected to create demand for yellow fever vaccines and medication. This, in turn, will play a key role in fostering growth of the global yellow fever treatment industry in the coming years,” says a senior analyst at CMI.”
Rising cases of yellow fever in Colombia, as well as high mortality rates, will likely encourage people to opt for different treatments. Government and healthcare organizations in the nations may increase vaccination programs to prevent outbreaks. This can fuel demand for yellow fever vaccines and other treatments during the forecast period.
Amid yellow fever outbreaks, such as that of Colombia, regulatory bodies may increase fast-track approval of new treatments like vaccines. This can encourage pharmaceutical companies to invest more in yellow fever research.
Leading companies in the global yellow fever industry are expected to heavily invest in research and development to create new vaccines and medications with better safety and efficacy. This will further boost growth of the target industry in the coming years.
Sources:
News Outlet: Reuters
